November 2, 2011

Medivation Announces Third Quarter Financial Results Teleconference and Webcast on November 9, 2011

SAN FRANCISCO, CA -- (MARKET WIRE) -- 11/02/11 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a teleconference and webcast with management to discuss third quarter financial results and provide a general business update on Wednesday, November 9, 2011 at 4:30 p.m. Eastern Time. A press release for the third quarter ended on September 30, 2011 will be released after markets close on November 9, 2011.

Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals interested in listening to the live call via webcast may do so by visiting the "Events and Presentations" page of the "Investor Relations" section of the Company's website at www.medivation.com. A replay also will be available for 30 days following the live presentation.

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Astellas and Pfizer, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer and mild-to-moderate Alzheimer's disease. For more information, please visit us at www.medivation.com.

Contacts:

Patrick Machado

Chief Business & Financial Officer

(415) 829-4101



Anne Bowdidge

Investor Relations

(650) 218-6900



Source: Medivation

News Provided by Acquire Media


Close window | Back to top

Copyright 2014 Medivation, Inc.